RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.

Fibromyalgia: Pregabalin for the Treatment of Fibromyalgia

Rae GleasonOn June 21, 2007, the Food and Drug Administration approved the use of Lyrica for the treatment of fibromyalgia. Historically, this is a big first step in helping healthcare professionals have a viable, proven, treatment option for this illness. Following is an article by Dr. Patrick Wood, a published fibromyalgia researcher, describing the scientific research on this medication and the resulting recommended use of Lyrica in this patient population.

— Rae Marie Gleason
Department Head


 Patrick WoodPatrick B. Wood, MD

On June 21, 2007, the U.S. Food and Drug Administration (FDA) announced its approval of pregabalin (Lyrica

Last updated on: February 22, 2011
SHOW MAIN MENU
SHOW SUB MENU